The most common side effects are gastrointestinal , such as mild nausea, bloating, or constipation, particularly in the early stages of dose adjustment
Res.) to match the weight loss of GLP-1MK-801 ( n = 8 mice and n = 5 cages) or vehicle (isotonic saline, n = 8 mice and n = 5 cages) for 4 days
Rare risks associated with GLP-1 medications include: Pancreatitis , or inflammation of the pancreas Gallstones and inflammation of the gallbladder leading to biliary colic, sometimes related to rapid weight loss Kidney issues , often linked to dehydration Thyroid tumor warnings , based on animal studies rather than confirmed human cases These risks underscore the importance of medical supervision throughout your treatment
In healthy individuals, GIP(3-30)NH 2 infusions inhibit GIP-potentiated glucose-stimulated insulin secretion (75), thereby confirming GIPs role as a potent incretin hormone (16, 87)
However, the body also clears it quite fast